An international team led by a University of Pittsburgh School of Medicine scientist has created a first-of-its-kind resource ...

Pittsburgh researchers develop a genetic tool that detects hidden risks for high LDL cholesterol, aiding early prevention of heart attacks and strokes.

Scientists have developed a groundbreaking genetic map. This resource identifies individuals at risk for high cholesterol and heart disease. It works ...

Heart disease is still the number one cause of death among adults worldwide. High cholesterol levels are one contributor to heart disease.. | Genetics And Genomics ...

An international research consortium co-led by scientists from Vanderbilt University Medical Center, the University of Toronto and University of Pittsburgh has mapped the functional impact of more ...

Researchers have developed a DNA-based therapy that targets the PCSK9 gene to lower cholesterol naturally. Using polypurine ...

With Eli Lilly's recent acquisition of Verve Therapeutics and its PCSK9 candidate, delve into what the target represents.

Amgen to present new data from cardiovascular portfolio, including late-breaking results from phase 3 VESALIUS-CV trial of Repatha at AHA scientific sessions: Thousand Oaks, Calif ...

The problem with the liver’s strategy of dumping excess cholesterol into the gut is that some of it ends up re-absorbed back into the body ...